can lab bpc 157 BPC-157 – No Proof Required! | Office for Science and Society BPC-157 — Technical Lot Record
Description
What made the discovery remarkable was not just the peptide's origin but its behavior
Figure 9b : Patella maltracking with patella alta and oedema in the superior lateral aspect of Hoffas fat pad, consistent with Hoffas fat pad entrapment (blue arrow, sagittal view, PD/FS)
In the Phase 2 trial, the 4 mg group had already lost 12.9% of body weight by week 24, compared to 1.6% for placebo
Some clinicians use TA1 offlabel to support patients with autoimmune disease, citing its ability to modulate the immune system without broad suppression
